Anvision Healthtech has been selected as a recipient of the Ngee Ann Kongsi-SUSS Impact Grant 2025, recognising our work in advancing impact driven healthcare innovation.

We extend our sincere appreciation to Ngee Ann Kongsi and the Singapore University of Social Sciences (SUSS) for their trust and support of founders committed to creating meaningful social impact. This grant represents a strong affirmation of both the problem we are addressing and the communities we aim to serve.

Advancing Early Diagnosis Through Technology

Anvision Healthtech works closely with AI developers and healthcare stakeholders to develop early diagnostic solutions that improve access to care, particularly for underserved and resource limited populations. By leveraging digital and AI-driven technologies, we seek to address systemic gaps in early detection and enable timely intervention that can significantly improve health outcomes.

The support from this grant will enable us to accelerate the development, validation, and deployment of our solutions, ensuring they remain accessible, affordable, and clinically relevant across diverse care settings.

Strengthening Sustainable, Impact-Driven Innovation

Being selected for the Ngee Ann Kongsi-SUSS Impact Grant provides meaningful encouragement as we continue building a purpose-driven healthtech venture. It reinforces our commitment to developing solutions that deliver measurable, long-term impact while remaining grounded in real world needs.

We are deeply grateful for this recognition and for the opportunity to work alongside partners who share a vision for impact led innovation. With this support, Anvision Healthtech looks forward to taking further steps toward expanding access to healthcare and driving sustainable positive change.